Discover
PCRX
Pacira BioSciences, Inc.
25.03
2 x 18.30
2 x 31.80
bid
ask
-
0.34
1.34%
2 @ 04:00 PM
25.44 +0.41 (1.64%)
| Ytd | -3.28% | |
| 1y | 7.66% |
24.59
day range
25.85
18.80
52 week range
27.64
| Open | 25.75 | Prev Close | 25.37 | Low | 24.59 | High | 25.85 | Mkt Cap | 984.88M |
| Vol | 543.14K | Avg Vol | 528.55K | EPS | 0.13 | P/E | 192.54 | Forward P/E | 6.87 |
| Beta | 0.20 | Short Ratio | 11.24 | Inst. Own | 118.81% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-30 | 50-d Avg | 23.69 | 200-d Avg | 23.41 | 1yr Est | 29.00 |
| Income Statement | |||
| Total Revenue | 177.38M | ||
| Revenues (USD) | 177.38M | ||
| Cost of Revenue | 36.41M | ||
| Gross Profit | 140.96M | ||
| Operating Expenses | 134.06M | ||
| Research and Development Expense | 28.07M | ||
| Selling, General and Administrative Expense | 93.94M | ||
| Operating Income | 6.90M | ||
| Interest Expense | 3.70M | ||
| Income Tax Expense | 2.08M | ||
| Net Income | 2.92M | ||
| Net Income Common Stock | 2.92M | ||
| Net Income Common Stock (USD) | 2.92M | ||
| Consolidated Income | 2.92M | ||
| Earnings per Basic Share | 0.07 | ||
| Earnings per Basic Share (USD) | 0.07 | ||
| Earnings per Diluted Share | 0.07 | ||
| Earning Before Interest & Taxes (EBIT) | 8.70M | ||
| Earning Before Interest & Taxes (USD) | 8.70M | ||
| Weighted Average Shares | 40.46M | ||
| Weighted Average Shares Diluted | 40.91M | ||
| Balance Sheet | |||
| Cash and Equivalents | 144.31M | ||
| Cash and Equivalents (USD) | 144.31M | ||
| Investments | 80.64M | ||
| Investments Current | 57.87M | ||
| Investments Non-Current | 22.77M | ||
| Trade and Non-Trade Receivables | 125.64M | ||
| Current Assets | 514.96M | ||
| Property, Plant & Equipment Net | 175.69M | ||
| Total Assets | 1.21B | ||
| Debt Current | 9.82M | ||
| Total Debt | 411.18M | ||
| Current Liabilities | 108.79M | ||
| Debt Non-Current | 401.36M | ||
| Total Liabilities | 554.64M | ||
| Accumulated Retained Earnings (Deficit) | -196.41M | ||
| Accumulated Other Comprehensive Income | 3.46M | ||
| Shareholders Equity | 653.89M | ||
| Shareholders Equity (USD) | 653.89M | ||
| Assets Non-Current | 693.57M | ||
| Total Debt (USD) | 411.18M | ||
| Goodwill and Intangible Assets | 373.00M | ||
| Inventory | 150.37M | ||
| Liabilities Non-Current | 445.85M | ||
| Trade and Non-Trade Payables | 14.01M | ||
| Tax Assets | 122.12M | ||
| Tax Liabilities | 4.09M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 21.33M | ||
| Net Cash Flow from Financing | -59.40M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -14.24M | ||
| Capital Expenditure | -2.72M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -335.00K | ||
| Issuance (Purchase) of Equity Shares | -50.04M | ||
| Issuance (Repayment) of Debt Securities | -5.00M | ||
| Net Cash Flow from Investing | 19.44M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 22.50M | ||
| Net Cash Flow from Operations | 25.68M | ||
| Effect of Exchange Rate Changes on Cash | 38.00K | ||
| Share Based Compensation | 13.54M | ||